123 related articles for article (PubMed ID: 23580146)
1. Genetic stabilization of transthyretin, cerebrovascular disease, and life expectancy.
Hornstrup LS; Frikke-Schmidt R; Nordestgaard BG; Tybjærg-Hansen A
Arterioscler Thromb Vasc Biol; 2013 Jun; 33(6):1441-7. PubMed ID: 23580146
[TBL] [Abstract][Full Text] [Related]
2. Transthyretin-stabilising mutation T119M is not associated with protection against vascular disease or death in the UK Biobank.
Parker MM; Ticau S; Butler J; Erbe D; Merkel M; Aldinc E; Hinkle G; Nioi P
Amyloid; 2020 Sep; 27(3):184-190. PubMed ID: 32425064
[No Abstract] [Full Text] [Related]
3. Promotor polymorphisms in leukotriene C4 synthase and risk of ischemic cerebrovascular disease.
Freiberg JJ; Tybjaerg-Hansen A; Sillesen H; Jensen GB; Nordestgaard BG
Arterioscler Thromb Vasc Biol; 2008 May; 28(5):990-6. PubMed ID: 18276912
[TBL] [Abstract][Full Text] [Related]
4. Comparative studies of two transthyretin variants with protective effects on familial amyloidotic polyneuropathy: TTR R104H and TTR T119M.
Almeida MR; Alves IL; Terazaki H; Ando Y; Saraiva MJ
Biochem Biophys Res Commun; 2000 Apr; 270(3):1024-8. PubMed ID: 10772944
[TBL] [Abstract][Full Text] [Related]
5. Association of Low Plasma Transthyretin Concentration With Risk of Heart Failure in the General Population.
Greve AM; Christoffersen M; Frikke-Schmidt R; Nordestgaard BG; Tybjærg-Hansen A
JAMA Cardiol; 2021 Mar; 6(3):258-266. PubMed ID: 33237279
[TBL] [Abstract][Full Text] [Related]
6. Genetic inhibition of CETP, ischemic vascular disease and mortality, and possible adverse effects.
Johannsen TH; Frikke-Schmidt R; Schou J; Nordestgaard BG; Tybjærg-Hansen A
J Am Coll Cardiol; 2012 Nov; 60(20):2041-8. PubMed ID: 23083790
[TBL] [Abstract][Full Text] [Related]
7. R104H may suppress transthyretin amyloidogenesis by thermodynamic stabilization, but not by the kinetic mechanism characterizing T119 interallelic trans-suppression.
Sekijima Y; Dendle MT; Wiseman RL; White JT; D'Haeze W; Kelly JW
Amyloid; 2006 Jun; 13(2):57-66. PubMed ID: 16911959
[TBL] [Abstract][Full Text] [Related]
8. Genetic variation in liver X receptor alpha and risk of ischemic vascular disease in the general population.
Stender S; Frikke-Schmidt R; Anestis A; Kardassis D; Sethi AA; Nordestgaard BG; Tybjærg-Hansen A
Arterioscler Thromb Vasc Biol; 2011 Dec; 31(12):2990-6. PubMed ID: 21903943
[TBL] [Abstract][Full Text] [Related]
9. Association of Transthyretin Val122Ile Variant With Incident Heart Failure Among Black Individuals.
Parcha V; Malla G; Irvin MR; Armstrong ND; Judd SE; Lange LA; Maurer MS; Levitan EB; Goyal P; Arora G; Arora P
JAMA; 2022 Apr; 327(14):1368-1378. PubMed ID: 35377943
[TBL] [Abstract][Full Text] [Related]
10. Common polymorphisms in CYP2C9, subclinical atherosclerosis and risk of ischemic vascular disease in 52,000 individuals.
Kaur-Knudsen D; Bojesen SE; Nordestgaard BG
Pharmacogenomics J; 2009 Oct; 9(5):327-32. PubMed ID: 19652664
[TBL] [Abstract][Full Text] [Related]
11. Integrin beta3 Leu33Pro polymorphism and risk of hip fracture: 25 years follow-up of 9233 adults from the general population.
Tofteng CL; Bach-Mortensen P; Bojesen SE; Tybjaerg-Hansen A; Hyldstrup L; Nordestgaard BG
Pharmacogenet Genomics; 2007 Jan; 17(1):85-91. PubMed ID: 17264806
[TBL] [Abstract][Full Text] [Related]
12. Susceptibility and modifier genes in Portuguese transthyretin V30M amyloid polyneuropathy: complexity in a single-gene disease.
Soares ML; Coelho T; Sousa A; Batalov S; Conceição I; Sales-Luís ML; Ritchie MD; Williams SM; Nievergelt CM; Schork NJ; Saraiva MJ; Buxbaum JN
Hum Mol Genet; 2005 Feb; 14(4):543-53. PubMed ID: 15649951
[TBL] [Abstract][Full Text] [Related]
13. Hereditary hemochromatosis genotypes and risk of ischemic stroke.
Ellervik C; Tybjaerg-Hansen A; Appleyard M; Sillesen H; Boysen G; Nordestgaard BG
Neurology; 2007 Mar; 68(13):1025-31. PubMed ID: 17389307
[TBL] [Abstract][Full Text] [Related]
14. Association between interleukin-6 levels and first-ever cerebrovascular events in patients with vascular risk factors.
Miwa K; Tanaka M; Okazaki S; Furukado S; Sakaguchi M; Mochizuki H; Kitagawa K
Arterioscler Thromb Vasc Biol; 2013 Feb; 33(2):400-5. PubMed ID: 23175672
[TBL] [Abstract][Full Text] [Related]
15. Heterozygosity for R1141X in ABCC6 and risk of ischemic vascular disease.
Hornstrup LS; Tybjærg-Hansen A; Haase CL; Nordestgaard BG; Sillesen H; Grande P; Frikke-Schmidt R
Circ Cardiovasc Genet; 2011 Oct; 4(5):534-41. PubMed ID: 21831958
[TBL] [Abstract][Full Text] [Related]
16. Biochemical and clinical characterization of prealbuminCHICAGO: an apparently benign variant of serum prealbumin (transthyretin) discovered with high-resolution two-dimensional electrophoresis.
Harrison HH; Gordon ED; Nichols WC; Benson MD
Am J Med Genet; 1991 Jun; 39(4):442-52. PubMed ID: 1877623
[TBL] [Abstract][Full Text] [Related]
17. Mitochondrial haplogroups: ischemic cardiovascular disease, other diseases, mortality, and longevity in the general population.
Benn M; Schwartz M; Nordestgaard BG; Tybjaerg-Hansen A
Circulation; 2008 May; 117(19):2492-501. PubMed ID: 18458168
[TBL] [Abstract][Full Text] [Related]
18. Association between a functional variant of the KLOTHO gene and high-density lipoprotein cholesterol, blood pressure, stroke, and longevity.
Arking DE; Atzmon G; Arking A; Barzilai N; Dietz HC
Circ Res; 2005 Mar; 96(4):412-8. PubMed ID: 15677572
[TBL] [Abstract][Full Text] [Related]
19. Transthyretin: no association between serum levels or gene variants and schizophrenia.
Ruano D; Macedo A; Soares MJ; Valente J; Azevedo MH; Hutz MH; Gama CS; Lobato MI; Belmonte-de-Abreu P; Goodman AB; Pato C; Saraiva MJ; Heutink P; Palha JA
J Psychiatr Res; 2007 Oct; 41(8):667-72. PubMed ID: 16716350
[TBL] [Abstract][Full Text] [Related]
20. Genetically increased antioxidative protection and decreased chronic obstructive pulmonary disease.
Juul K; Tybjaerg-Hansen A; Marklund S; Lange P; Nordestgaard BG
Am J Respir Crit Care Med; 2006 Apr; 173(8):858-64. PubMed ID: 16399992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
